Skip to main content

5 Stock Gainers for Monday: Imara, Barrick Gold, Azure Power Global

Imara, Azure Power Global, Barrick Gold, Clovis Oncology and GrowGeneration are some of the big gainers for Monday.
  • Author:
  • Publish date:

Stocks were finished mixed Monday as the S&P 500 fell just short of a record close. 

The U.S. and China - the world's two largest economies--postponed a weekend meeting to discuss progress of their phase one trade agreement.

Investors bought up shares from a variety of industries, including biotechnology, utilities, and gold. Here are some of the top gainers for Monday:

1. Imara | Percentage Increase Over 15%

Shares of Imara  (IMRA)  jumped after Citi analyst Yigal Nochomovitz upgraded the pharmaceutical company to buy from neutral with a price target of $30, down from $34. The company said it received encouraging news for IMR-687, its sickle cell disease treatment. 

TheStreet Recommends

2. Azure Power Global | Percentage Increase Over 9%

Azure Power Global  (AZRE) - Get Azure Power Global Ltd. Report advanced after the operator of solar-power plants in India  beat Wall Street's first-quarter-earnings expectations. Adjusted earnings were 7 cents a share, ahead of the Zacks consensus estimate of a loss of 23 cents. Revenue totaled $52.2 million, up 16% from a year earlier and edging out the Zacks estimate of $51 million.

3. Barrick Gold | Percentage Increase Over 11%

Barrick Gold  (GOLD) - Get Barrick Gold Corporation Report shares were higher after Warren Buffet's Berkshire Hathaway undefined took a new 1.2% stake in the gold mining company. Berkshire Hathaway also exited or reduced holdings in shares of financial companies in the quarter ended July 1. 

4. Clovis Oncology | Percentage Increase Over 20%

Clovis Oncology  (CLVS) - Get Clovis Oncology, Inc. Report climbed after the biopharmaceutical company said a Phase II study of Rubraca, its treatment for metastatic castration-resistant prostate cancer, supported the May U.S. Food and Drug Administration accelerated approval of Rubraca for the treatment. The results were published in the Journal of Clinical Oncology.

5. GrowGeneration | Percentage Increase Over 22%

GrowGeneration  (GRWG) - Get GrowGeneration Corp. Report advanced after the specialty hydroponic and organic gardening retailer recently reported its 10th consecutive quarter of record revenue. Sales more than doubled from a year earlier to $43.5 million. Same-store sales were up 49% from a year ago.